| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | EML-425 |
|---|
| Description | EML-425 is a potent, reversible and non-competitive dual CBP and p300 inhibitor (IC50 values are 1.1 and 2.9 μM, respectively). EML425 induced a marked and time-dependent reduction in the acetylation of lysine H4K5 and H3K9, a marked arrest in the G0/G1 phase and a significant increase in the hypodiploid nuclei percentage in human leukemia U937 cells. Cell-permeable. MW: 440.49. Purity ≥98% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 5-[(4-Hydroxy-2,6-dimethylphenyl)methylene]-1,3-bis(phenylmethyl)-2,4,6(1H,3H,5H)-pyrimidinetrione |
|---|
| Gene, Accession, CAS # | CAS: 1675821-32-5 |
|---|
| Catalog # | B1882-5 |
|---|
| Price | |
|---|
| Order / More Info | EML-425 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|